Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AVIR - Atea Pharmaceuticals Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q1 2022 Results - Earnings Call Transcript

AVIR - Atea Pharmaceuticals Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q1 2022 Results - Earnings Call Transcript

Atea Pharmaceuticals Inc.
Atea Pharmaceuticals, Inc. (AVIR) Q1 2022 Earnings Conference Call May 10, 2022 8:00 a.m. ET Company Participants Jean-Pierre Sommadossi - Founder & CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO & EVP, Legal John Vavricka - Chief Commercial Officer Jonae Barnes - SVP, IR & Corporate Communications Conference Call Participants Hannah Colgan - JPMorgan Umer Raffat - Evercore Nik Gasic - SVB Securities Jonathan Miller - Evercore Presentation Operator Good morning, and welcome to the Atea Pharmaceuticals First Quarter 2022 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode to prevent any background noise. And following management’s prepared remarks, the call will be opened for your questions. [Operator instructions]. Please be advised that today’s call is being recorded. I will now turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at Atea Pharmaceuticals. Please proceed. Jonae

For further details see:

Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Atea Pharmaceuticals Inc.
Stock Symbol: AVIR
Market: NASDAQ
Website: ateapharma.com
Menu
AVIR AVIR Quote AVIR Short AVIR News AVIR Articles AVIR Message Board
Get AVIR Alerts

News, Short Squeeze, Breakout and More Instantly...